BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12796143)

  • 1. Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels.
    Tateyama M; Kurokawa J; Terrenoire C; Rivolta I; Kass RS
    Circulation; 2003 Jul; 107(25):3216-22. PubMed ID: 12796143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
    Clancy CE; Tateyama M; Kass RS
    J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel.
    Gründer S; Firsov D; Chang SS; Jaeger NF; Gautschi I; Schild L; Lifton RP; Rossier BC
    EMBO J; 1997 Mar; 16(5):899-907. PubMed ID: 9118951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.
    Clancy CE; Tateyama M; Liu H; Wehrens XH; Kass RS
    Circulation; 2003 May; 107(17):2233-7. PubMed ID: 12695286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.
    Rivolta I; Clancy CE; Tateyama M; Liu H; Priori SG; Kass RS
    Physiol Genomics; 2002 Sep; 10(3):191-7. PubMed ID: 12209021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
    Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
    J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant.
    Liu K; Yang T; Viswanathan PC; Roden DM
    Circulation; 2005 Nov; 112(21):3239-46. PubMed ID: 16301357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome.
    Smits JP; Veldkamp MW; Bezzina CR; Bhuiyan ZA; Wedekind H; Schulze-Bahr E; Wilde AA
    Cardiovasc Res; 2005 Aug; 67(3):459-66. PubMed ID: 16039271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C.
    Chen Y; Yu FH; Surmeier DJ; Scheuer T; Catterall WA
    Neuron; 2006 Feb; 49(3):409-20. PubMed ID: 16446144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furin cleavage activates the epithelial Na+ channel by relieving Na+ self-inhibition.
    Sheng S; Carattino MD; Bruns JB; Hughey RP; Kleyman TR
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1488-96. PubMed ID: 16449353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits.
    An RH; Wang XL; Kerem B; Benhorin J; Medina A; Goldmit M; Kass RS
    Circ Res; 1998 Jul; 83(2):141-6. PubMed ID: 9686753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
    Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
    Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
    Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
    Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase.
    Lee HC; Patel MK; Mistry DJ; Wang Q; Reddy S; Moorman JR; Mounsey JP
    Physiol Genomics; 2003 Jan; 12(2):147-57. PubMed ID: 12454205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome.
    Huang H; Millat G; Rodriguez-Lafrasse C; Rousson R; Kugener B; Chevalier P; Chahine M
    FEBS Lett; 2009 Mar; 583(5):890-6. PubMed ID: 19302788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.